Scilex Holding (SCLX) EBT (2020 - 2026)
Scilex Holding (SCLX) posted EBT of -$115.0 million for Q2 2026, down 151.87% on a QoQ basis from -$45.6 million in Q1 2026, and down 161.14% year-over-year from $188.0 million in Q2 2025.
Analysis
Scilex Holding (SCLX) EBT (2020 - 2026) Analysis & Trends
Scilex Holding has reported EBT for 7 years, with the latest figure at -$115.0 million in Q2 2026.
- On a quarterly basis, EBT fell 161.14% year-over-year to -$115.0 million in Q2 2026; TTM through Jun 2026 was -$464.5 million, a 473.81% decrease from a year earlier, with the FY2025 full-year figure at -$374.0 million, down 413.72% from the prior year.
- EBT was -$115.0 million for Q2 2026 at Scilex Holding, down from -$45.6 million in the prior quarter.
- The five-year high for EBT was $21.5 million in Q3 2022, with the low at -$257.8 million in Q3 2025.
- Average EBT over 5 years is -$41.4 million, with a median of -$26.4 million recorded in 2023.
- The largest YoY upside for EBT was 7732.69% in 2022 against a maximum downside of 10705.02% in 2022.
- Over 5 years, EBT stood at -$17.8 million in 2022, then retreated by 19.88% to -$21.4 million in 2023, then soared by 69.8% to -$6.5 million in 2024, then sank by 613.5% to -$46.1 million in 2025, then sank by 149.42% to -$115.0 million in 2026.
- The last three EBT figures came in at -$115.0 million (Q2 2026), -$45.6 million (Q1 2026), and -$46.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.64 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 751.51 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 372.70 Mn |
| 10 | Scilex Holding | 35.91 Mn | -76.88 Mn | 3.97 Mn | -114.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -114.98 Mn |
| Mar 31, 2026 | -45.65 Mn |
| Dec 31, 2025 | -46.10 Mn |
| Sep 30, 2025 | -257.82 Mn |
| Jun 30, 2025 | -44.03 Mn |
| Mar 31, 2025 | -26.08 Mn |
| Dec 31, 2024 | -6.46 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -37.58 Mn |
| Mar 31, 2024 | -24.38 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -35.53 Mn |
| Jun 30, 2023 | -26.65 Mn |
| Mar 31, 2023 | -30.75 Mn |
| Dec 31, 2022 | -17.84 Mn |
| Sep 30, 2022 | 21.49 Mn |
| Jun 30, 2022 | -17.87 Mn |
| Mar 31, 2022 | -9.14 Mn |
| Dec 31, 2021 | -35.26 Mn |
| Sep 30, 2021 | -281,552.00 |